Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Dr Reddys, Manipal Hospitals join hands for Sputnik V

Ruchika Sharma7 Jun 2021 11:00 AM IST

New Delhi: Leading hospital chain Manipal Hospitals on Sunday said it has collaborated with Dr Reddy''s Laboratories to add the Sputnik V COVID-19...

Sanofi partnering with leading academics to study amcenestrant for breast cancer treatment

Ruchika Sharma7 Jun 2021 10:30 AM IST

Amcenestrant is an oral SERD that antagonizes and degrades the estrogen receptor (ER), resulting in inhibition of the ER signaling pathway.

Haryana to decide on offer of 60 million Sputnik V doses for Rs 1120 per dose

Ruchika Sharma7 Jun 2021 10:00 AM IST

Chandigarh: The Haryana cabinet will take a final decision after the state government received an offer from a pharmaceutical company based in Malta...

Bayer begins Phase I study with GIRK4 inhibitor for atrial fibrillation

Bayer launches Consumer Health division in India comprising 10 brands in allergy, dermatology, others

Ruchika Sharma6 Jun 2021 11:00 AM IST

New Delhi: Global life sciences firm Bayer on Friday said it has launched its Consumer Health division in India comprising 10 brands across the...

Biological E to supply 30 crore COVID vaccine doses to Centre

Ruchika Sharma6 Jun 2021 10:30 AM IST

New Delhi: The Union Health Ministry has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to reserve 30 crore COVID-19...

Bharat Biotech - Ocugen agreement amended to expand Covaxin commercialization rights to include Canada

Ruchika Sharma6 Jun 2021 10:00 AM IST

Hyderabad: Bharat Biotech and Ocugen have announced that they have entered into an amendment to their Co-development, Supply, and...

COVID-19: Reliance seeks Govt nod to import JnJ vaccine for its workforce in India

Ruchika Sharma6 Jun 2021 9:30 AM IST

New Delhi: Reliance Foundation, the philanthropic arm of the Mukesh Ambani-led Reliance Industries, has sought the government''s authorisation to...

Pfizer-BioNTech COVID vaccine approved for 12- to 15-year-olds in UK

Ruchika Sharma6 Jun 2021 9:00 AM IST

London: Britain's medicines regulator said on Friday it had approved the Covid-19 vaccine developed by Pfizer and BioNTech for use on 12- to...

CDSCO panel nod to Zydus antibodies cocktail trials to treat COVID

Ruchika Sharma5 Jun 2021 1:03 PM IST

Zydus said that its biological therapy ZRC-3308, a cocktail of two SARS-CoV-2-neutralising monoclonal antibodies (mAbs) can emerge as one of the main...

Glenmark Theophylline ER Tablets gets USFDA approval

Ruchika Sharma5 Jun 2021 12:30 PM IST

Mumbai: Drugmaker, Glenmark Pharmaceuticals Limited, has recently announced that the company has received final approval by the United States Food...

Serum Institute bags DCGI nod for Covid vaccine Sputnik V

Ruchika Sharma5 Jun 2021 12:10 PM IST

New Delhi: The DCGI has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik Covid-19 vaccine in India for examination,...

Lupin bags tentative USFDA nod for rare autoimmune disorder drug Amifampridine

Lupin to introduce healthcare space for doctors, patients with Lupin Digital Health in India

Ruchika Sharma5 Jun 2021 11:00 AM IST

New Delhi: Drug major Lupin on Thursday said it will enter the digital healthcare space in India with a focus to provide a digital therapeutics...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok